Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure: A Preliminary Study
Exhaled acetone concentration is one of the expected compounds to be a breath biomarker in heart failure. However, it has not been clarified how exhaled acetone concentration changes in clinical course of heart failure.To investigate whether exhaled acetone concentration changes after treatment in a...
Gespeichert in:
| Veröffentlicht in: | International Heart Journal 2018/07/31, Vol.59(4), pp.808-812 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 812 |
|---|---|
| container_issue | 4 |
| container_start_page | 808 |
| container_title | International Heart Journal |
| container_volume | 59 |
| creator | Yokokawa, Tetsuro Sato, Takamasa Suzuki, Satoshi Oikawa, Masayoshi Yoshihisa, Akiomi Kobayashi, Atsushi Yamaki, Takayoshi Kunii, Hiroyuki Nakazato, Kazuhiko Suzuki, Hitoshi Saitoh, Shu-ichi Ishida, Takafumi Shimouchi, Akito Takeishi, Yasuchika |
| description | Exhaled acetone concentration is one of the expected compounds to be a breath biomarker in heart failure. However, it has not been clarified how exhaled acetone concentration changes in clinical course of heart failure.To investigate whether exhaled acetone concentration changes after treatment in acute decompensated heart failure (ADHF).This study included 19 patients with ADHF (ADHF group) and eight patients with stable heart failure (control group). Exhaled acetone was collected from these patients, and the concentration was measured with gas chromatography.The ADHF group had higher heart rates (P = 0.046), higher New York Heart Association class (P < 0.001), higher levels of brain natriuretic peptide (P = 0.026), blood total ketone bodies (P = 0.015), and exhaled acetone concentration (P < 0.001), compared with the control group. In ADHF group, exhaled acetone concentration significantly decreased after treatment (median: 2.40 versus 0.92 ppm, P < 0.001). However, in the control group, exhaled acetone concentration did not significantly change (median: 0.73 versus 0.49 ppm, P = 0.141).In these preliminary findings, exhaled acetone concentration in patients with ADHF drastically decreased by treatment. Serial exhaled acetone measurement might be useful to evaluate the course of ADHF. |
| doi_str_mv | 10.1536/ihj.17-482 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2230590314</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2230590314</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-6cc0db57321490f82ebe55e726d8ad126050e531f067006613a1e27bda4adf73</originalsourceid><addsrcrecordid>eNo9kMlOwzAQhiMEEqVw4QkscUNK8RI7zY2qtBSpEhx6t1xn0iRK7WI7LG-PS6peZkYz32x_ktwTPCGciaembickT7MpvUhGhGVFymhRXJ5iygS_Tm68bzHOCMf5KFHzWpkdIFuhxU-tOijRTEOwBtDcGg0mOBUaa9AavqDzqDHoIyZi3qPvJtSR7gOgF9B2fwDjVYgTVqBcQEvVdL2D2-SqUp2Hu5MfJ5vlYjNfpev317f5bJ3qeGFIhda43PKcUZIVuJpS2ALnkFNRTlVJqMAcA2ekwiLHWAjCFAGab0uVqbLK2Th5GMYenP3swQfZ2t6ZuFFSyjAvMCNZpB4HSjvrvYNKHlyzV-5XEiyPCsqooCS5jApG-HmAWx_UDs5ofK7RHfyjvJDZ0Qwt55KulZNg2B-z_3q5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2230590314</pqid></control><display><type>article</type><title>Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure: A Preliminary Study</title><source>J-STAGE Free</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Yokokawa, Tetsuro ; Sato, Takamasa ; Suzuki, Satoshi ; Oikawa, Masayoshi ; Yoshihisa, Akiomi ; Kobayashi, Atsushi ; Yamaki, Takayoshi ; Kunii, Hiroyuki ; Nakazato, Kazuhiko ; Suzuki, Hitoshi ; Saitoh, Shu-ichi ; Ishida, Takafumi ; Shimouchi, Akito ; Takeishi, Yasuchika</creator><creatorcontrib>Yokokawa, Tetsuro ; Sato, Takamasa ; Suzuki, Satoshi ; Oikawa, Masayoshi ; Yoshihisa, Akiomi ; Kobayashi, Atsushi ; Yamaki, Takayoshi ; Kunii, Hiroyuki ; Nakazato, Kazuhiko ; Suzuki, Hitoshi ; Saitoh, Shu-ichi ; Ishida, Takafumi ; Shimouchi, Akito ; Takeishi, Yasuchika</creatorcontrib><description>Exhaled acetone concentration is one of the expected compounds to be a breath biomarker in heart failure. However, it has not been clarified how exhaled acetone concentration changes in clinical course of heart failure.To investigate whether exhaled acetone concentration changes after treatment in acute decompensated heart failure (ADHF).This study included 19 patients with ADHF (ADHF group) and eight patients with stable heart failure (control group). Exhaled acetone was collected from these patients, and the concentration was measured with gas chromatography.The ADHF group had higher heart rates (P = 0.046), higher New York Heart Association class (P < 0.001), higher levels of brain natriuretic peptide (P = 0.026), blood total ketone bodies (P = 0.015), and exhaled acetone concentration (P < 0.001), compared with the control group. In ADHF group, exhaled acetone concentration significantly decreased after treatment (median: 2.40 versus 0.92 ppm, P < 0.001). However, in the control group, exhaled acetone concentration did not significantly change (median: 0.73 versus 0.49 ppm, P = 0.141).In these preliminary findings, exhaled acetone concentration in patients with ADHF drastically decreased by treatment. Serial exhaled acetone measurement might be useful to evaluate the course of ADHF.</description><identifier>ISSN: 1349-2365</identifier><identifier>EISSN: 1349-3299</identifier><identifier>DOI: 10.1536/ihj.17-482</identifier><language>eng</language><publisher>Tokyo: International Heart Journal Association</publisher><subject>Acetone ; Biomarker ; Brain natriuretic peptide ; Breath analysis ; Congestive heart failure ; Gas chromatography ; Heart failure ; Ketone body ; Ketones ; Patients</subject><ispartof>International Heart Journal, 2018/07/31, Vol.59(4), pp.808-812</ispartof><rights>2018 by the International Heart Journal Association</rights><rights>Copyright Japan Science and Technology Agency 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c299t-6cc0db57321490f82ebe55e726d8ad126050e531f067006613a1e27bda4adf73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,1879,27907,27908</link.rule.ids></links><search><creatorcontrib>Yokokawa, Tetsuro</creatorcontrib><creatorcontrib>Sato, Takamasa</creatorcontrib><creatorcontrib>Suzuki, Satoshi</creatorcontrib><creatorcontrib>Oikawa, Masayoshi</creatorcontrib><creatorcontrib>Yoshihisa, Akiomi</creatorcontrib><creatorcontrib>Kobayashi, Atsushi</creatorcontrib><creatorcontrib>Yamaki, Takayoshi</creatorcontrib><creatorcontrib>Kunii, Hiroyuki</creatorcontrib><creatorcontrib>Nakazato, Kazuhiko</creatorcontrib><creatorcontrib>Suzuki, Hitoshi</creatorcontrib><creatorcontrib>Saitoh, Shu-ichi</creatorcontrib><creatorcontrib>Ishida, Takafumi</creatorcontrib><creatorcontrib>Shimouchi, Akito</creatorcontrib><creatorcontrib>Takeishi, Yasuchika</creatorcontrib><title>Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure: A Preliminary Study</title><title>International Heart Journal</title><addtitle>Int. Heart J.</addtitle><description>Exhaled acetone concentration is one of the expected compounds to be a breath biomarker in heart failure. However, it has not been clarified how exhaled acetone concentration changes in clinical course of heart failure.To investigate whether exhaled acetone concentration changes after treatment in acute decompensated heart failure (ADHF).This study included 19 patients with ADHF (ADHF group) and eight patients with stable heart failure (control group). Exhaled acetone was collected from these patients, and the concentration was measured with gas chromatography.The ADHF group had higher heart rates (P = 0.046), higher New York Heart Association class (P < 0.001), higher levels of brain natriuretic peptide (P = 0.026), blood total ketone bodies (P = 0.015), and exhaled acetone concentration (P < 0.001), compared with the control group. In ADHF group, exhaled acetone concentration significantly decreased after treatment (median: 2.40 versus 0.92 ppm, P < 0.001). However, in the control group, exhaled acetone concentration did not significantly change (median: 0.73 versus 0.49 ppm, P = 0.141).In these preliminary findings, exhaled acetone concentration in patients with ADHF drastically decreased by treatment. Serial exhaled acetone measurement might be useful to evaluate the course of ADHF.</description><subject>Acetone</subject><subject>Biomarker</subject><subject>Brain natriuretic peptide</subject><subject>Breath analysis</subject><subject>Congestive heart failure</subject><subject>Gas chromatography</subject><subject>Heart failure</subject><subject>Ketone body</subject><subject>Ketones</subject><subject>Patients</subject><issn>1349-2365</issn><issn>1349-3299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo9kMlOwzAQhiMEEqVw4QkscUNK8RI7zY2qtBSpEhx6t1xn0iRK7WI7LG-PS6peZkYz32x_ktwTPCGciaembickT7MpvUhGhGVFymhRXJ5iygS_Tm68bzHOCMf5KFHzWpkdIFuhxU-tOijRTEOwBtDcGg0mOBUaa9AavqDzqDHoIyZi3qPvJtSR7gOgF9B2fwDjVYgTVqBcQEvVdL2D2-SqUp2Hu5MfJ5vlYjNfpev317f5bJ3qeGFIhda43PKcUZIVuJpS2ALnkFNRTlVJqMAcA2ekwiLHWAjCFAGab0uVqbLK2Th5GMYenP3swQfZ2t6ZuFFSyjAvMCNZpB4HSjvrvYNKHlyzV-5XEiyPCsqooCS5jApG-HmAWx_UDs5ofK7RHfyjvJDZ0Qwt55KulZNg2B-z_3q5</recordid><startdate>20180731</startdate><enddate>20180731</enddate><creator>Yokokawa, Tetsuro</creator><creator>Sato, Takamasa</creator><creator>Suzuki, Satoshi</creator><creator>Oikawa, Masayoshi</creator><creator>Yoshihisa, Akiomi</creator><creator>Kobayashi, Atsushi</creator><creator>Yamaki, Takayoshi</creator><creator>Kunii, Hiroyuki</creator><creator>Nakazato, Kazuhiko</creator><creator>Suzuki, Hitoshi</creator><creator>Saitoh, Shu-ichi</creator><creator>Ishida, Takafumi</creator><creator>Shimouchi, Akito</creator><creator>Takeishi, Yasuchika</creator><general>International Heart Journal Association</general><general>Japan Science and Technology Agency</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope></search><sort><creationdate>20180731</creationdate><title>Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure</title><author>Yokokawa, Tetsuro ; Sato, Takamasa ; Suzuki, Satoshi ; Oikawa, Masayoshi ; Yoshihisa, Akiomi ; Kobayashi, Atsushi ; Yamaki, Takayoshi ; Kunii, Hiroyuki ; Nakazato, Kazuhiko ; Suzuki, Hitoshi ; Saitoh, Shu-ichi ; Ishida, Takafumi ; Shimouchi, Akito ; Takeishi, Yasuchika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-6cc0db57321490f82ebe55e726d8ad126050e531f067006613a1e27bda4adf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acetone</topic><topic>Biomarker</topic><topic>Brain natriuretic peptide</topic><topic>Breath analysis</topic><topic>Congestive heart failure</topic><topic>Gas chromatography</topic><topic>Heart failure</topic><topic>Ketone body</topic><topic>Ketones</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yokokawa, Tetsuro</creatorcontrib><creatorcontrib>Sato, Takamasa</creatorcontrib><creatorcontrib>Suzuki, Satoshi</creatorcontrib><creatorcontrib>Oikawa, Masayoshi</creatorcontrib><creatorcontrib>Yoshihisa, Akiomi</creatorcontrib><creatorcontrib>Kobayashi, Atsushi</creatorcontrib><creatorcontrib>Yamaki, Takayoshi</creatorcontrib><creatorcontrib>Kunii, Hiroyuki</creatorcontrib><creatorcontrib>Nakazato, Kazuhiko</creatorcontrib><creatorcontrib>Suzuki, Hitoshi</creatorcontrib><creatorcontrib>Saitoh, Shu-ichi</creatorcontrib><creatorcontrib>Ishida, Takafumi</creatorcontrib><creatorcontrib>Shimouchi, Akito</creatorcontrib><creatorcontrib>Takeishi, Yasuchika</creatorcontrib><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><jtitle>International Heart Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yokokawa, Tetsuro</au><au>Sato, Takamasa</au><au>Suzuki, Satoshi</au><au>Oikawa, Masayoshi</au><au>Yoshihisa, Akiomi</au><au>Kobayashi, Atsushi</au><au>Yamaki, Takayoshi</au><au>Kunii, Hiroyuki</au><au>Nakazato, Kazuhiko</au><au>Suzuki, Hitoshi</au><au>Saitoh, Shu-ichi</au><au>Ishida, Takafumi</au><au>Shimouchi, Akito</au><au>Takeishi, Yasuchika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure: A Preliminary Study</atitle><jtitle>International Heart Journal</jtitle><addtitle>Int. Heart J.</addtitle><date>2018-07-31</date><risdate>2018</risdate><volume>59</volume><issue>4</issue><spage>808</spage><epage>812</epage><pages>808-812</pages><issn>1349-2365</issn><eissn>1349-3299</eissn><abstract>Exhaled acetone concentration is one of the expected compounds to be a breath biomarker in heart failure. However, it has not been clarified how exhaled acetone concentration changes in clinical course of heart failure.To investigate whether exhaled acetone concentration changes after treatment in acute decompensated heart failure (ADHF).This study included 19 patients with ADHF (ADHF group) and eight patients with stable heart failure (control group). Exhaled acetone was collected from these patients, and the concentration was measured with gas chromatography.The ADHF group had higher heart rates (P = 0.046), higher New York Heart Association class (P < 0.001), higher levels of brain natriuretic peptide (P = 0.026), blood total ketone bodies (P = 0.015), and exhaled acetone concentration (P < 0.001), compared with the control group. In ADHF group, exhaled acetone concentration significantly decreased after treatment (median: 2.40 versus 0.92 ppm, P < 0.001). However, in the control group, exhaled acetone concentration did not significantly change (median: 0.73 versus 0.49 ppm, P = 0.141).In these preliminary findings, exhaled acetone concentration in patients with ADHF drastically decreased by treatment. Serial exhaled acetone measurement might be useful to evaluate the course of ADHF.</abstract><cop>Tokyo</cop><pub>International Heart Journal Association</pub><doi>10.1536/ihj.17-482</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1349-2365 |
| ispartof | International Heart Journal, 2018/07/31, Vol.59(4), pp.808-812 |
| issn | 1349-2365 1349-3299 |
| language | eng |
| recordid | cdi_proquest_journals_2230590314 |
| source | J-STAGE Free; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Acetone Biomarker Brain natriuretic peptide Breath analysis Congestive heart failure Gas chromatography Heart failure Ketone body Ketones Patients |
| title | Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure: A Preliminary Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T20%3A53%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Change%20of%20Exhaled%20Acetone%20Concentration%20Levels%20in%20Patients%20with%20Acute%20Decompensated%20Heart%20Failure:%20A%20Preliminary%20Study&rft.jtitle=International%20Heart%20Journal&rft.au=Yokokawa,%20Tetsuro&rft.date=2018-07-31&rft.volume=59&rft.issue=4&rft.spage=808&rft.epage=812&rft.pages=808-812&rft.issn=1349-2365&rft.eissn=1349-3299&rft_id=info:doi/10.1536/ihj.17-482&rft_dat=%3Cproquest_cross%3E2230590314%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2230590314&rft_id=info:pmid/&rfr_iscdi=true |